New Clinical Trial Data Shows Modern Blood Thinners Cut Stroke Risks for Intermediate-Risk Atrial Fibrillation Patients
A major new randomized clinical trial has delivered compelling evidence that newer blood-thinning medications can substantially decrease the incidence of serious cardiovascular complications among individuals diagnosed with atrial fibrillation who…